Technologies
The Company has exclusive rights to patents controlling many significant uses of AFPs, for example:
The use of antifreeze proteins in the cryogenic-hypothermic preservation of mammalian cells, tissues and organs
The use of antifreeze proteins to cryoablate human tumor cells
